Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: A randomized study

Vincenzo Tullo, Fabio Valguarnera, Piero Barbanti, Pietro Cortelli, Giuliano Sette, Gianni Allais, Florindo D'Onofrio, Marcella Curone, Dario Zava, Deborha Pezzola, Chiara Benedetto, Fabio Frediani, Gennaro Bussone

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Drugs for migraine attacks include triptans and NSAIDs; their combination could provide greater symptom relief. Methods: A total of 314 subjects with history of migraine, with or without aura, were randomized to frovatriptan 2.5 mg alone (Frova), frovatriptan 2.5 mgdexketoprofen 25 mg (FroDex25) or frovatriptan 2.5 mgdexketoprofen 37.5 mg (FroDex37.5) and treated at least one migraine attack. This was a multicenter, randomized, double-blind, parallel-group study. The primary end point was the proportion of pain free (PF) at two hours. Secondary end points were PF at one and four hours, pain relief (PR) at one, two, four hours, sustained PF (SPF) at 24 and 48 hours, recurrence at 48 hours, resolution of nausea, photophobia and phonophobia at two and four hours, the use of rescue medication and the judgment of the treatment. Results: The results were assessed in the full analysis set (FAS) population, which included all subjects randomized and treated for whom at least one post-dose intensity of headache was recorded. The proportions of subjects PF at two hours (primary end point) were 29% (27/93) with Frova compared with 51% (48/95 FroDex25 and 46/91 FroDex37.5) with each combination therapies (p

Original languageEnglish
Pages (from-to)434-445
Number of pages12
JournalCephalalgia
Volume34
Issue number6
DOIs
Publication statusPublished - 2014

Keywords

  • dexketoprofen
  • Frovatriptan
  • migraine attacks
  • NSAIDs
  • triptans

ASJC Scopus subject areas

  • Clinical Neurology
  • Medicine(all)

Fingerprint

Dive into the research topics of 'Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: A randomized study'. Together they form a unique fingerprint.

Cite this